Table 1.
Laboratory investigation findings of the presented case with acute myopathy following SARS-CoV2 infection
| Investigations (normal value and unit of measurement) | Patient value on admission and range during hospital stay |
|---|---|
| Hemoglobin (13.5-17.5 g/dl) | 14.5 (14.5-9.2) |
| Total leukocyte count (4500 to 11,000/μl) | 21,100 (10,170-31,780) |
| Polymorph (40-65%) | 93% (62-94) |
| Lymphocyte (30-50%) | 4% (4-36) |
| Total platelet count (150,000 to 400,000/μl) | 295,000 (270,000 to 480,000/μl) |
| C-reactive protein (< 5 mg/L) | 300 (2.7-300) |
| Serum procalcitonin (0.10-0.49 ng/mL) | 5.69 (0.27-5.69) |
| Serum ferritin (< 250 ng/mL) | 811 (799-2185) |
| Serum d-dimer (< 0.4 mcg/mL) | 1.25 (1.25-5.55) |
| Serum PT (11-13.5 s) | 13 (13-15) |
| Serum aPTT (25-35 s) | 33 (30-33) |
| Serum CPK (< 120 mcg/mL) | 850 (637-1325) |
| Serum electrolytes | |
| Na+ (135-145) mmol/L | 138 (134-152) |
| K+ (3.5-5.5) mmol/L | 4.6 (3.5-5.1) |
| Ca+ (8.5-10.5) mg/dl | 8.6 (7.6-8.6) |
| Mg+(1.5-2.5) mmol/L | 1.9 (1.9-3) |
| Serum creatinine (60-110 μmol/L) | 87 (71-155) |
| Serum SGPT (7-56 U/L) | 32 (32-45) |
| Serum troponin-I (< 0.04 ng/ml) | 0.02 (0.02-0.2) |
| Serum Pro-BNP (< 125 pg/mL) | 130 (109-130) |
| Serum anti GM1 antibody | (− ve) |
| Cerebrospinal fluid (CSF) | |
| Total protein (up to 45 mg/dl) | 10 |
| Total WBC count (0-5/cmm) | 05 |
PT prothrombin time, aPTT activated partial thromboplastin time, CPK creatinine phosphokinase, SGPT serum glutamic pyruvic transaminase, BNP brain natriuretic peptide, WBC white blood cells